For years, transvaginal mesh—also known as a bladder sling—has been used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI) in women.

However, increasing reports of severe health complications related to this medical device induced a recent Food and Drug Administration (FDA) advisory and prompted numerous lawsuits against manufacturers of transvaginal mesh.